Walter Reed and remaining GLP studies this month and then we move in first human trials in next 1-2 months.
Walter Reed results shortly secures phase 2 funding with the US defence force. Also the first of its kind and NYR once GLP is passed will own this drug class. For peers to be valued 100-200 million market caps having gone through safety NYR 9 million market cap. Need safety on GLP coming to an end
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.82M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 31.0¢ | $213.4K | 643.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 29064 | 2 |
View Market Depth
| Last trade - 15.59pm 23/07/2025 (20 minute delay) ? |
| NYR (ASX) Chart |